chr17-32996987-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_173847.5(SPACA3):c.488G>A(p.Arg163Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,556,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_173847.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPACA3 | NM_173847.5 | c.488G>A | p.Arg163Gln | missense_variant | 3/5 | ENST00000269053.8 | |
SPACA3 | NM_001317225.2 | c.212G>A | p.Arg71Gln | missense_variant | 3/5 | ||
SPACA3 | NM_001317226.2 | c.179G>A | p.Arg60Gln | missense_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPACA3 | ENST00000269053.8 | c.488G>A | p.Arg163Gln | missense_variant | 3/5 | 1 | NM_173847.5 | A2 | |
SPACA3 | ENST00000580599.5 | c.281G>A | p.Arg94Gln | missense_variant | 4/6 | 1 | P2 | ||
SPACA3 | ENST00000394637.2 | n.631G>A | non_coding_transcript_exon_variant | 3/5 | 1 | ||||
SPACA3 | ENST00000394638.1 | c.179G>A | p.Arg60Gln | missense_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000982 AC: 20AN: 203732Hom.: 0 AF XY: 0.0000551 AC XY: 6AN XY: 108836
GnomAD4 exome AF: 0.0000299 AC: 42AN: 1404132Hom.: 0 Cov.: 31 AF XY: 0.0000317 AC XY: 22AN XY: 694242
GnomAD4 genome AF: 0.000256 AC: 39AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74514
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at